Drug comparisons
Dapagliflozin vs Insulin Degludec
Compare Dapagliflozin (Farxiga) an SGLT2 inhibitor vs Insulin Degludec (Tresiba) a long-acting insulin for type 2 diabetes, noting black box warning.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when intensifying type 2 diabetes therapy from an oral SGLT2 inhibitor to or with basal insulin.
Bottom line
Dapagliflozin and Insulin Degludec offer complementary but distinct approaches to glycemic control with neither being universally superior.
All medication comparisons